26 November 2021
: Case report
A New Potential Strategy for Acute Non-Alcoholic Steatohepatitis (NASH)
Unusual or unexpected effect of treatment
Anupamjeet Kaur Sekhon1BDEF*, Aniruddha Gollapalli1E, Dharamjeet Kaur2E, Bryan Janssen3D, Mark L. StevensDOI: 10.12659/AJCR.932961
Am J Case Rep 2021; 22:e932961
Figure 3. Lipid panel values in a graph with elevated values before PCSK9 inhibitor treatment and decreasing after initiation of therapy.






